ROCKWELL MEDICAL, INC. (RMTI) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, ROCKWELL MEDICAL, INC.'s filing signal continuing negative.

Rockwell Medical is a healthcare company specializing in the development, manufacturing, and distribution of hemodialysis products, primarily serving dialysis providers in the United States and internationally. The company is a key supplier of both liquid and dry acid and bicarbonate concentrates, essential for treating end-stage kidney disease. Manufacturing occurs at facilities in Michigan and Texas, with dry acid concentrate mixers produced in Iowa, adhering to cGMP regulations. Rockwell delivers its products via its own fleet and third-party carriers, leveraging a reputation for quality and reliability. In 2025, the company expanded its product line with a new single-use bicarbonate cartridge and secured a multi-year purchase agreement with Innovative Renal Care, while also extending its agreement with DaVita.

Revenue is primarily driven by the sale of hemodialysis concentrates, including liquid and dry acid and bicarbonate products, to dialysis clinics and distributors. Ancillary products and license fees also contribute to revenue.